Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele

Podobne zapisy

• Hyperbilirubinemia in atazanavir treated HIV-infected patients: the impact of the UGT1A1*28 allele
  od: Panagopoulos, Periklis, i wsp.
  Wydane: (2017)
• Association between the UGT1A1*28 allele and hyperbilirubinemia in HIV-positive patients receiving atazanavir: a meta-analysis
  od: Du, Pengqiang, i wsp.
  Wydane: (2019)
• Effect of genetic variation in UGT1A and ABCB1 on moxifloxacin pharmacokinetics in South African patients with tuberculosis
  od: Naidoo, Anushka, i wsp.
  Wydane: (2018)
• Understanding the Profile of Tuberculosis and Human Immunodeficiency Virus Coinfection: Insights from Expanded HIV Surveillance at a Tuberculosis Facility in Durban, South Africa
  od: Perumal, Rubeshan, i wsp.
  Wydane: (2014)
• Analysis of the UGT1A1 Genotype in Hyperbilirubinemia Patients: Differences in Allele Frequency and Distribution
  od: Mi, Xiao-xiao, i wsp.
  Wydane: (2019)